PubMed:33754144 / 398-577 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/33754144","sourcedb":"PubMed","sourceid":"33754144","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/33754144","text":"We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T4","span":{"begin":0,"end":179},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":179},"obj":"Sentence"}],"attributes":[{"subj":"T4","pred":"source","obj":"Inflammaging"},{"subj":"T4","pred":"source","obj":"Inflammaging"}]},{"project":"yangbin123xm_800_3","denotations":[{"id":"T2","span":{"begin":129,"end":147},"obj":"DP"},{"id":"T6","span":{"begin":29,"end":41},"obj":"CI"}],"attributes":[{"subj":"T2","pred":"source","obj":"yangbin123xm_800_3"},{"subj":"T6","pred":"source","obj":"yangbin123xm_800_3"}]},{"project":"chenxin_473849_800_3","denotations":[{"id":"T7","span":{"begin":29,"end":41},"obj":"CI"},{"id":"T16","span":{"begin":129,"end":147},"obj":"DP"}],"attributes":[{"subj":"T7","pred":"source","obj":"chenxin_473849_800_3"},{"subj":"T16","pred":"source","obj":"chenxin_473849_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#ecaf93","default":true},{"id":"yangbin123xm_800_3","color":"#9593ec"},{"id":"chenxin_473849_800_3","color":"#aaec93"}]}]}}